About
Sitagliptin and Metformin is a widely used fixed-dose combination for the treatment of type 2 diabetes mellitus. Sitagliptin is a DPP-4 inhibitor that enhances the body's ability to lower high blood sugar levels by increasing the release of insulin from the pancreas and decreasing the release of sugar from the liver, both in a glucose-dependent manner. Metformin, a biguanide, primarily reduces glucose production by the liver and improves insulin sensitivity in peripheral tissues. This combination provides complementary mechanisms of action to achieve robust glycemic control, addressing both impaired insulin secretion and insulin resistance. It is often prescribed when metformin alone does not provide adequate blood sugar control.
Uses
- Management of type 2 diabetes mellitus.
- Improvement of glycemic control.
- When diet and exercise are insufficient.
- As an add-on to other antidiabetic agents.
Directions For Use
Take this medication orally, usually twice daily with meals, or as directed by your physician. Swallow the tablets whole.
Benefits
- Provides effective blood glucose lowering.
- Significantly reduces HbA1c levels.
- Low risk of hypoglycemia when used alone.
- Generally weight-neutral.
- Improves both fasting and postprandial glucose.
- Convenient fixed-dose combination.
Side Effects
- Nausea
- Diarrhea
- Abdominal pain
- Headache
- Nasopharyngitis
- Upper respiratory tract infection
- Hypoglycemia (when combined with sulfonylureas/insulin)
- Lactic acidosis (rare, due to metformin)
- Pancreatitis (rare, due to sitagliptin)
- Joint pain (arthralgia)
- Vitamin B12 deficiency (long-term metformin use)
- Allergic reactions (rare)
Safety Measures
- Alcohol - Avoid excessive alcohol intake, especially with metformin, due to an increased risk of lactic acidosis.
- Pregnancy - Not recommended during pregnancy. Consult your doctor, as alternative treatments may be safer.
- Breastfeeding - Metformin is excreted in breast milk; sitagliptin's excretion is unknown. Use with caution; consult a healthcare professional.
- Liver - Contraindicated in severe liver impairment due to the metformin component. Sitagliptin requires caution.
- Kidney - Contraindicated in severe kidney impairment (eGFR <30 mL/min/1.73m²) due to metformin. Dosage adjustment needed for moderate impairment.
- Lung - Generally safe for use in patients with lung conditions; however, severe respiratory failure can increase lactic acidosis risk with metformin.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!